口服耐受的治疗潜力。 - Suppr

Suppr

超能文献

Therapeutic potential of oral tolerance.

作者信息

Mayer Lloyd, Shao Ling

机构信息

The Mount Sinai School of Medicine, Immunobiology Center, 1 Gustave L. Levy Place, New York 10029, USA.

出版信息

Nat Rev Immunol. 2004 Jun;4(6):407-19. doi: 10.1038/nri1370.

DOI:10.1038/nri1370

PMID:15173830

Abstract

摘要

相似文献

Therapeutic potential of oral tolerance.

Nat Rev Immunol. 2004 Jun;4(6):407-19. doi: 10.1038/nri1370.

Oral tolerance: can we make it work?

Hum Immunol. 2009 Oct;70(10):768-76. doi: 10.1016/j.humimm.2009.06.018. Epub 2009 Jun 25.

Food for thought: can immunological tolerance be induced to treat asthma?

Am J Respir Cell Mol Biol. 2001 May;24(5):509-12. doi: 10.1165/ajrcmb.24.5.f207.

Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction.

Immunology. 2006 Oct;119(2):167-77. doi: 10.1111/j.1365-2567.2006.02418.x. Epub 2006 Jun 23.

Insights into the mechanism of oral tolerance derived from the study of models of mucosal inflammation.

Ann N Y Acad Sci. 2004 Dec;1029:115-31. doi: 10.1196/annals.1309.029.

Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.

Immunology. 2006 Jul;118(3):311-20. doi: 10.1111/j.1365-2567.2006.02368.x.

Current issues in the treatment of human diseases by mucosal tolerance.

Ann N Y Acad Sci. 2004 Dec;1029:211-24. doi: 10.1196/annals.1309.053.

Mesenteric lymph nodes at the center of immune anatomy.

J Exp Med. 2006 Mar 20;203(3):497-500. doi: 10.1084/jem.20060227. Epub 2006 Mar 13.

Oral tolerance in the treatment of inflammatory autoimmune diseases.

Inflamm Res. 1999 Mar;48(3):106-19. doi: 10.1007/s000110050433.

Oral tolerance: therapeutic implications for autoimmune diseases.

Clin Dev Immunol. 2006 Jun-Dec;13(2-4):143-57. doi: 10.1080/17402520600876804.

引用本文的文献

Immune Modulation with Oral DNA/RNA Nanoparticles.

Pharmaceutics. 2025 May 4;17(5):609. doi: 10.3390/pharmaceutics17050609.

Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.

Front Immunol. 2024 Sep 2;15:1419527. doi: 10.3389/fimmu.2024.1419527. eCollection 2024.

Vaccines for Respiratory Viruses-COVID and Beyond.

Vaccines (Basel). 2024 Aug 22;12(8):936. doi: 10.3390/vaccines12080936.

Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract.

Sci Adv. 2024 May 31;10(22):eadn7786. doi: 10.1126/sciadv.adn7786. Epub 2024 May 29.

Oral mucosa effectively protects against peanut allergy in mice.

J Allergy Clin Immunol. 2024 Oct;154(4):1060-1068. doi: 10.1016/j.jaci.2024.05.012. Epub 2024 May 23.

Recent development of oral vaccines (Review).

Exp Ther Med. 2024 Mar 22;27(5):223. doi: 10.3892/etm.2024.12511. eCollection 2024 May.

Oral alloantigen exposure promotes donor-specific tolerance in a mouse model of minor-mismatched skin transplantation.

Am J Transplant. 2022 Oct;22(10):2348-2359. doi: 10.1111/ajt.17107. Epub 2022 Jun 16.

Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges.

Immun Inflamm Dis. 2022 Apr;10(4):e604. doi: 10.1002/iid3.604.

The immunomodulatory effects of long-term supplementation with Lactobacillus casei Shirota depend on ovalbumin presentation in BALB/c mice.

Sci Rep. 2021 Sep 30;11(1):19478. doi: 10.1038/s41598-021-98791-2.

Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches.

Immunotargets Ther. 2021 Jul 2;10:213-224. doi: 10.2147/ITT.S276874. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Therapeutic potential of oral tolerance.

作者信息

Mayer Lloyd, Shao Ling

机构信息

The Mount Sinai School of Medicine, Immunobiology Center, 1 Gustave L. Levy Place, New York 10029, USA.

出版信息

Nat Rev Immunol. 2004 Jun;4(6):407-19. doi: 10.1038/nri1370.

DOI:10.1038/nri1370

PMID:15173830

Abstract

摘要

相似文献

Therapeutic potential of oral tolerance.

Nat Rev Immunol. 2004 Jun;4(6):407-19. doi: 10.1038/nri1370.

Oral tolerance: can we make it work?

Hum Immunol. 2009 Oct;70(10):768-76. doi: 10.1016/j.humimm.2009.06.018. Epub 2009 Jun 25.

Food for thought: can immunological tolerance be induced to treat asthma?

Am J Respir Cell Mol Biol. 2001 May;24(5):509-12. doi: 10.1165/ajrcmb.24.5.f207.

Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction.

Immunology. 2006 Oct;119(2):167-77. doi: 10.1111/j.1365-2567.2006.02418.x. Epub 2006 Jun 23.

Insights into the mechanism of oral tolerance derived from the study of models of mucosal inflammation.

Ann N Y Acad Sci. 2004 Dec;1029:115-31. doi: 10.1196/annals.1309.029.

Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.

Immunology. 2006 Jul;118(3):311-20. doi: 10.1111/j.1365-2567.2006.02368.x.

Current issues in the treatment of human diseases by mucosal tolerance.

Ann N Y Acad Sci. 2004 Dec;1029:211-24. doi: 10.1196/annals.1309.053.

Mesenteric lymph nodes at the center of immune anatomy.

J Exp Med. 2006 Mar 20;203(3):497-500. doi: 10.1084/jem.20060227. Epub 2006 Mar 13.

Oral tolerance in the treatment of inflammatory autoimmune diseases.

Inflamm Res. 1999 Mar;48(3):106-19. doi: 10.1007/s000110050433.

Oral tolerance: therapeutic implications for autoimmune diseases.

Clin Dev Immunol. 2006 Jun-Dec;13(2-4):143-57. doi: 10.1080/17402520600876804.

引用本文的文献

Immune Modulation with Oral DNA/RNA Nanoparticles.

Pharmaceutics. 2025 May 4;17(5):609. doi: 10.3390/pharmaceutics17050609.

Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.

Front Immunol. 2024 Sep 2;15:1419527. doi: 10.3389/fimmu.2024.1419527. eCollection 2024.

Vaccines for Respiratory Viruses-COVID and Beyond.

Vaccines (Basel). 2024 Aug 22;12(8):936. doi: 10.3390/vaccines12080936.

Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract.

Sci Adv. 2024 May 31;10(22):eadn7786. doi: 10.1126/sciadv.adn7786. Epub 2024 May 29.

Oral mucosa effectively protects against peanut allergy in mice.

J Allergy Clin Immunol. 2024 Oct;154(4):1060-1068. doi: 10.1016/j.jaci.2024.05.012. Epub 2024 May 23.

Recent development of oral vaccines (Review).

Exp Ther Med. 2024 Mar 22;27(5):223. doi: 10.3892/etm.2024.12511. eCollection 2024 May.

Oral alloantigen exposure promotes donor-specific tolerance in a mouse model of minor-mismatched skin transplantation.

Am J Transplant. 2022 Oct;22(10):2348-2359. doi: 10.1111/ajt.17107. Epub 2022 Jun 16.

Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges.

Immun Inflamm Dis. 2022 Apr;10(4):e604. doi: 10.1002/iid3.604.

The immunomodulatory effects of long-term supplementation with Lactobacillus casei Shirota depend on ovalbumin presentation in BALB/c mice.

Sci Rep. 2021 Sep 30;11(1):19478. doi: 10.1038/s41598-021-98791-2.

Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches.

Immunotargets Ther. 2021 Jul 2;10:213-224. doi: 10.2147/ITT.S276874. eCollection 2021.